Skip to content

The effectiveness of a short-term schema focused group therapy on persistent anxiety and depressive symptoms: A Single Case Experimental Design

The effectiveness of a short-term schema focused group therapy on persistent anxiety and depressive symptoms: A Single Case Experimental Design - Schema focused group therapy for anxiety and depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53660
Enrollment
10
Registered
2023-06-21
Start date
2023-07-18
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angststoornis en klachten Anxiety and depression

Interventions

There are two intervention phases. The first concerns the pre-treatment phase, which consists of five online sessions and three face-to-face sessions with one of the group therapists. Pre-treatment

Sponsors

GGZ Noord-Holland-Noord
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Clients currently in treatment at GGZ-NHN (mental health organization), who meet the following criteria: - Persistent anxiety or depression symptoms (at least moderate score at the subscale depression (>=7 or anxiety >=6 on the DASS-21). - History of at least one previous evidence-based therapy focused on anxiety, depression or PTSD according to the Dutch national guidelines. - Able to comprehend Dutch at a level sufficient to complete the self-report questionnaires. - Age between 18-65.

Exclusion criteria

Exclusion criteria: - Clients with severe problems that need to be addressed first, including substance abuse, psychosis, anxiety disorder, PTSD or depression that not have been treated. - Start of (or change in) medication which is not yet stabilized at the start of this study. - Psychosocial problems such as homelessness, no income or high debts which would make the clients unable to participate in a group.

Design outcomes

Primary

MeasureTime frame
Anxiety and depressive symptoms, as measured by (an idiosyncratically chosen set of) a self-report questionnaire (DASS-21)

Secondary

MeasureTime frame
Dysfunctional schemas, experiential avoidance, and healthy adult mode, all measured by (an idiosyncratically chosen set of) self-assessment questionnaires (YSQ-S3, BEAQ, SMI, respectively). Furthermore, by means of self-report scales we also examine the degree of personality pathology (LPFS-BF) and general psychopathology (OQ-45).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026